TROG’s Facility Alliance Members (FAM) are the cornerstone of our collaborative outreach, supporting the implementation and delivery of TROG trials. In this series, we feature some of the many facilities that play a key role in advancing TROG trials, enabling us to recruit participants from diverse backgrounds. SITE NAME:
LATEST NEWS: 16 June 2026 TROG members highlighted cutting-edge radiation therapy research being led from Australia during wide-ranging presentations at the 17th International Stereotactic Radiosurgery Society (ISRS) Congress. The biennial congress, held in Sydney from 31 May – 3 June, brought together world-leading experts in stereotactic radiosurgery and radiation
9 April 2026 TROG Cancer Research honours the life and legacy of Radiation Oncologist Professor Jim Denham OAM, a founding member and pioneering researcher whose contributions have been central to the organisation’s more than 35-year history. Jim passed away in March 2026 at the age of 75, leaving a
LATEST NEWS: 31 March 2026 TROG’s inaugural Secondary Data Analysis (SDA) grant has been awarded to an early-career researcher who will draw on data from a TROG trial of radiation therapy for prostate cancer to gain a better understanding of long-term patient outcomes. Dr Therese Kang, a Radiation Oncologist
LATEST NEWS: 26 March 2026 We are delighted to announce the appointment of a new President-Elect as well as two new Elected Directors to the TROG Cancer Research Board, as ratified at our Annual General Meeting (AGM) last week. A/Prof Hien Le, the current chair of the TROG Scientific
LATEST NEWS: 26 March 2026 TROG’s 2026 Annual Scientific Meeting (ASM) paved the way for innovative future research, exploring vital issues ranging from boosting consumer engagement in research to the way in which AI could reshape clinical trials of the future. Over 350 delegates gathered at the Pullman Albert
LATEST NEWS: 25 March 2026 TROG Cancer Research proudly celebrated the outstanding contributions of its members at our 2026 Research Excellence Awards (the ‘TROGIES’) this month, recognising those who are helping to advance radiation medicine through impactful clinical research. We congratulate the following winners on well-deserved awards, which were
SPECIAL INTEREST GROUP IN FOCUS: 10 December 2025 Dr Anna Lawless is a Sydney-based Radiation Oncologist working in head and neck cancers, with an interest in using advanced imaging and biomarker-guided approaches to refine radiotherapy and support better outcomes for patients. She was recently appointed as Chair of the
LATEST NEWS: 4 December 2025 TROG provided a kick-start for a number of exciting new research ideas at the 2025 Concept Development Workshop held on 2 December. A total of 11 research concepts were submitted by TROG members from across a variety of disciplines (radiation oncology, radiation therapy and
LATEST NEWS; 26 November 2025 Medical physics researcher and TROG Member Professor Paul Keall has been honoured with two prestigious Premier’s Awards, recognising excellence and innovation in research in cancer imaging and radiation therapy technology, including in TROG clinical trials. Prof Keall was this month named: Congratulations to Prof
